NDATF (NDatalyze) Debt-to-Equity: 0.00 (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is NDatalyze Debt-to-Equity?

NDatalyze NDATF Debt-to-Equity is 0.00 as of Feb. 2026.

NDatalyze's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2026 was $0.00 Mil. NDatalyze's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2026 was $0.00 Mil. NDatalyze's Total Stockholders Equity for the quarter that ended in Feb. 2026 was $0.24 Mil. NDatalyze's debt to equity for the quarter that ended in Feb. 2026 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for NDatalyze's Debt-to-Equity or its related term are showing as below:

NDATF's Debt-to-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.405
* Ranked among companies with meaningful Debt-to-Equity only.

NDatalyze  (OTCPK:NDATF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

NDatalyze Debt-to-Equity Related Terms

NDatalyze Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for NDatalyze's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NDatalyze Debt-to-Equity Chart

NDatalyze Annual Data
Trend Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Debt-to-Equity
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

NDatalyze Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NDATF vs VEEV, BTSG, TEM: Debt-to-Equity Comparison

For the Health Information Services subindustry, NDatalyze's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NDatalyze Debt-to-Equity vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NDatalyze's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where NDatalyze's Debt-to-Equity falls into.


NDatalyze Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

NDatalyze's Debt to Equity Ratio for the fiscal year that ended in Feb. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 0.237
=0.00

NDatalyze's Debt to Equity Ratio for the quarter that ended in Feb. 2026 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 0.237
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of 0.00 mean?
NDatalyze (NDATF) has a Debt-to-Equity of 0.00 as of Feb. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on NDatalyze and its competitors.
Is NDatalyze's Debt-to-Equity too high?
NDatalyze's current Debt-to-Equity is 0.00.
How does NDatalyze's Debt-to-Equity compare to VEEV and BTSG?
NDatalyze's Debt-to-Equity of 0.00 can be compared against companies in the Healthcare Providers & Services industry. The industry median Debt-to-Equity is 0.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.41, based on 556 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on NDatalyze and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NDatalyze's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NDatalyze stock overvalued right now?
NDatalyze (NDATF) has a current Debt-to-Equity of 0.00. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 60% above its estimated fair value. The current Debt-to-Equity is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For NDatalyze (NDATF), the current Debt-to-Equity is 0.00 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NDatalyze Business Description

Other Exchanges NDAT:Canada
Address 707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6
NDatalyze Corp develops technologically-based, specialized products, databases, and applications. The YMI division is developing a data-driven consumer mHealth application designed to predict current and future health conditions to lessen the cost of health services and decrease the load on health care services. The MLdelic division is providing a database platform that may be used to predict potential benefits associated with the use of entheogenic compounds within the mental health sector. The Medxtractor division manufactures small-scale bio-extractors that are used to extract essential oils from botanical materials.